Completed OBSERVATIONAL NCT07057856
An Analysis of the Relationship Between the Genetic Polymorphisms of Interleukin 12 Receptor Subunit Beta 1 and Crohn's Disease in Chinese Patients
Sponsor: Second Affiliated Hospital of Wenzhou Medical University
Conditions
Crohn's Disease
Interventions
Ustekinumab (UST)
Updated 1 time since 2025 Last updated: Jun 30, 2025 Started: Jan 1, 2018 Primary completion: May 31, 2025 Completion: May 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07057856, this observational or N/A phase trial focuses on Crohn's Disease and remains completed. Sponsored by Second Affiliated Hospital of Wenzhou Medical University, it has been updated 1 time since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Completed
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Second Affiliated Hospital of Wenzhou Medical University
Data source: Second Affiliated Hospital of Wenzhou Medical University
For direct contact, visit the study record on ClinicalTrials.gov .